menu search

ABCM / How Much Upside is Left in Abcam PLC Sponsored ADR (ABCM)? Wall Street Analysts Think 27.55%

How Much Upside is Left in Abcam PLC Sponsored ADR (ABCM)? Wall Street Analysts Think 27.55%
The mean of analysts' price targets for Abcam PLC Sponsored ADR (ABCM) points to a 27.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock. Read More
Posted: May 23 2023, 11:08
Author Name: Zacks Investment Research
Views: 110319

ABCM News  

Exlusive: Why Abcam founder believes Danaher's acquisition offer falls short

By Proactive Investors
October 16, 2023

Exlusive: Why Abcam founder believes Danaher's acquisition offer falls short

In an exclusive interview with Thomas Warner (TW) of Proactive London, Dr Jonathan Milner (JM), the founder of life sciences company Abcam PLC (NASDAQ more_horizontal

GMED or ABCM: Which Is the Better Value Stock Right Now?

By Zacks Investment Research
October 5, 2023

GMED or ABCM: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Medical - Instruments sector might want to consider either Globus Medical (GMED) or Abcam PLC Sponsored ADR (ABCM) more_horizontal

Danaher Buys Abcam for $5.7 Billion to Expand Its Product Offerings

By Investopedia
August 28, 2023

Danaher Buys Abcam for $5.7 Billion to Expand Its Product Offerings

Medical tool supplier Danaher (DHR) is expanding its product offerings by purchasing British biotech firm Abcam Plc (ABCM) for $5.7 billion, including more_horizontal

Danaher acquires biotech supplier Abcam for $5.7B

By Proactive Investors
August 28, 2023

Danaher acquires biotech supplier Abcam for $5.7B

Danaher (NYSE:DHR) said it will be acquiring UK-based biotechnology supplier Abcam (AIM:ABC) for $24 per share or a total enterprise value of about $5 more_horizontal

Medical tech firm Danaher to buy Abcam in deal valued at $5.7 bln

By Reuters
August 28, 2023

Medical tech firm Danaher to buy Abcam in deal valued at $5.7 bln

Danaher Corp said on Monday it would buy smaller rival Abcam Plc in a deal valued at $5.7 billion including debt, as the medical tools supplier eyes b more_horizontal

Danaher to Buy Abcam in $5.7 Billion Deal. Investors Don't Like the Premium.

By Barrons
August 28, 2023

Danaher to Buy Abcam in $5.7 Billion Deal. Investors Don't Like the Premium.

The industrial scientific-supplies company agrees to acquire all shares outstanding for $24.00 each. more_horizontal

Abcam agrees to be acquired by Danaher in $5.7B deal

By Market Watch
August 28, 2023

Abcam agrees to be acquired by Danaher in $5.7B deal

Abcam Plc stock ABCM, +3.87% was up 0.4% in premarket trades Monday after it said it agreed to be acquired by Danaher Corp. DHR, +0.78% for $24 a shar more_horizontal

Exclusive: Danaher in the lead to acquire biomedical equipment vendor Abcam-sources

By Reuters
August 25, 2023

Exclusive: Danaher in the lead to acquire biomedical equipment vendor Abcam-sources

Danaher Corp is in the lead to acquire Abcam Plc , a provider of supplies to life science researchers with a market value of $5.1 billion, as it expan more_horizontal


Search within

Pages Search Results: